Overview

Prevalence and Treatment of Anemia in Rehabilitation Patients

Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Patients who are admitted to subacute rehabilitation facilities following hospitalization are frequently anemic. The purpose of this study is to see if anemic patients treated with epoetin alfa will have higher hemoglobin levels and better functional recovery at 3, 8, and 12 weeks after study entry compared to patients who do not receive epoetin alfa.
Phase:
Phase 4
Details
Lead Sponsor:
University of Medicine and Dentistry of New Jersey
Collaborator:
Ortho Biotech Clinical Affairs, L.L.C.
Treatments:
Epoetin Alfa
Iron